<DOC>
	<DOCNO>NCT01668693</DOCNO>
	<brief_summary>The purpose study demonstrate clinical efficiency Endometrial Receptivity Array ( ERA ) diagnostic tool patient repetitive implantation failure ( RIF ) , lead new concept personalize window implantation ( pWOI ) diagnostic treatment patient RIF endometrial origin .</brief_summary>
	<brief_title>ERA Test Patients With Recurrent Implantation Failure</brief_title>
	<detailed_description>Intervention ( ) : Endometrial sampling , either LH+7 natural cycle 5 day progesterone hormonal replacement cycle ( HRT ) personalize embryo transfer ( pET ) designate day guide ERA prediction . Repeated implantation failure ( RIF ) unsolved well characterized major cause infertility otherwise healthy woman . Although various definition RIF exist , clinical community agree failure three IVF cycle , one two morphologically high-grade embryo transfer , special protocol must enforce , although hard data RCTs demonstrate current approach RIF significant clinical value . Based large amount information generate regulation deregulation gene implicate endometrial window receptivity ( WOR ) , group develop molecular diagnostic tool base specific transcriptomic signature identifies receptive endometrium LH+7 natural cycle day 5 progesterone impregnation ( P+5 ) proper estradiol prim hormonal replacement therapy ( HRT ) cycle . The endometrial receptivity array ( ERA ) consist customized array contain 238 gene differentially express coupled computational predictor able diagnose personalize endometrial WOI give patient , regardless histological appearance . The accuracy diagnostic tool ERA demonstrate superior endometrial histology result completely reproducible 29 40 month later . Compelling evidence indicate existence endometrial receptivity alteration patient RIF . The aim study demonstrate diagnostic efficiency ERA test RIF patient identify putative alteration relate displacement personalize window receptivity , therapeutic implication personalization day embryo transfer ( pET ) , follow diagnosis obtain molecular diagnostic tool . An endometrial biopsy day LH+7 natural cycle day P+5 HRT cycle ERA diagnosis receptive non-receptive informed . In receptive case , embryo transfer ( ET ) perform subsequent cycle indicate day . In non-receptive ERA , test repeat dayindicated predictor , personalize ET guide subsequent cycle accord ERA diagnosis .</detailed_description>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Women ≤38 year old Normal ovarian reserve FSH &lt; 8mIU/mL Cycle ≥6 MII oocytes/oocyte retrieval ≥3 implantation failure previous IVF/ICSI cycle transfer atleast two good quality embryos cycle Inclusion Criteria ovum donation recipient ≥3 implantation failure transfer atleast two good quality embryos cycle Endometrial thickness ≥ 6 mm Trilaminar pattern proper progesterone prim Existance hydrosalpinx Atrophic endometrium &lt; 6 mm Previous ectopic uterine miscarriage Presence myoma polyp Previous embryo transfer high difficulty and/or bleed</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Endometrial receptivity</keyword>
	<keyword>recurrent implantation failure</keyword>
	<keyword>predictor tool</keyword>
	<keyword>ERA</keyword>
	<keyword>customize microarray</keyword>
	<keyword>personalize embryo transfer</keyword>
</DOC>